1. Home
  2. CRL
  3. CRL News

Latest Charles River Laboratories International Inc. (CRL) News on February 5, 2025

CRL Gears Up for Q4 Earnings: Here's What You Need to Know
CRL

Zacks

2 days ago

CRL Gears Up for Q4 Earnings: Here's What You Need to Know

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call
CRL

Business Wire

8 days ago

Charles River Laboratories Schedules Fourth-Quarter 2024 Earnings and 2025 Guidance Release and Conference Call

CRL

MT Newswires

13 days ago

Goldman Sachs Adjusts Charles River Laboratories International Price Target to $190 From $220, Maintains Buy Rating

Charles River downgraded to Market Perform from Outperform at William Blair
CRL

TipRanks

13 days ago

Charles River downgraded to Market Perform from Outperform at William Blair

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises
CRL

Zacks

14 days ago

Charles River Launches Apollo for CRADL to Boost Research, Stock Rises

CRL

MT Newswires

14 days ago

William Blair Downgrades Charles River Laboratories International to Market Perform From Outperform

CRL

MT Newswires

15 days ago

TD Cowen Adjusts Charles River Laboratories International Price Target to $182 From $227

RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL)
CRL

Insider Monkey

15 days ago

RiverWater Partners Sustainable Value Strategy Trimmed its Investment in Charles River Laboratories (CRL)

What Makes Charles River Labs (CRL) an Investment Bet?
CRL

Insider Monkey

15 days ago

What Makes Charles River Labs (CRL) an Investment Bet?

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
CRL

Business Wire

15 days ago

Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences

CRL

MT Newswires

19 days ago

Charles River Laboratories Mid-term Sales Growth Structurally Slowed Down, UBS Says

CRL

MT Newswires

19 days ago

UBS Downgrades Charles River Laboratories International to Neutral From Buy, Adjusts Price Target to $185 From $250

Charles River and Akron link to integrate cytokines into cell therapy
CRL

Pharmaceutical Technology

19 days ago

Charles River and Akron link to integrate cytokines into cell therapy

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?
CRL

Zacks

19 days ago

Will CRL Stock Gain From Integration of Akron Bio's CSS Product Line?

CRL

MT Newswires

20 days ago

Charles River Laboratories Partners With Akron Bio to Improve Cancer Treatment Platforms

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform
CRL

Business Wire

20 days ago

Charles River and Akron Bio Announce Collaboration to Enhance Operations with Integration of CGMP Materials into Cell Therapy Platform

CRL

Morningstar Research

21 days ago

Analyst Report: Charles River Laboratories International, Inc.

Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan
CRL

Pharmaceutical Technology

21 days ago

Charles River CEO reveals drop in 2025 revenue outlook at JP Morgan

CRL

MT Newswires

21 days ago

Jefferies Adjusts Price Target on Charles River Laboratories International to $169 From $196, Keeps Hold Rating

CRL

MT Newswires

21 days ago

Baird Adjusts Price Target on Charles River Laboratories International to $177 From $197, Keeps Neutral Rating

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference
CRL

Business Wire

23 days ago

Charles River Laboratories to Present at J.P. Morgan Healthcare Conference

Should You Retain Charles River Stock in Your Portfolio Now?
CRL

Zacks

a month ago

Should You Retain Charles River Stock in Your Portfolio Now?

Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects
CRL

Simply Wall St.

2 months ago

Earnings are growing at Charles River Laboratories International (NYSE:CRL) but shareholders still don't like its prospects

CRL

MT Newswires

2 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $245 From $250

CRL

MT Newswires

2 months ago

Morgan Stanley Trims Price Target on Charles River Laboratories International to $220 From $225, Keeps Equalweight Rating

Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?
CRL

Zacks

2 months ago

Why Is Charles River (CRL) Down 8.9% Since Last Earnings Report?

CRL Stock to Gain From the Global Biotech Incubator Program Launch
CRL

Zacks

2 months ago

CRL Stock to Gain From the Global Biotech Incubator Program Launch

Charles River Introduces Global Biotech Incubator Program
CRL

Business Wire

2 months ago

Charles River Introduces Global Biotech Incubator Program

Charles River Laboratories to Present at Evercore ISI Investor Conference
CRL

Business Wire

2 months ago

Charles River Laboratories to Present at Evercore ISI Investor Conference

At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?
CRL

Simply Wall St.

2 months ago

At US$200, Is It Time To Put Charles River Laboratories International, Inc. (NYSE:CRL) On Your Watch List?

Is it the Right Time to Hold Charles River Stock in Your Portfolio?
CRL

Zacks

2 months ago

Is it the Right Time to Hold Charles River Stock in Your Portfolio?

CRL

MT Newswires

2 months ago

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $220 From $240, Maintains Buy Rating

CRL

MT Newswires

2 months ago

Redburn Atlantic Adjusts PT on Charles River Laboratories International to $171 From $151, Maintains Sell Rating

CRL

MT Newswires

2 months ago

Baird Adjusts Price Target on Charles River Laboratories International to $197 From $211, Maintains Neutral Rating

CRL

Argus Research

3 months ago

Market Digest: APA, CBRL, CRL, DUK, SWKS, WWW, HUBS

CRL

Argus Research

3 months ago

Analyst Report: Charles River Laboratories Int

CRL

MT Newswires

3 months ago

Charles River Laboratories International Insider Sold Shares Worth $1,647,418, According to a Recent SEC Filing

CRL

MT Newswires

3 months ago

TD Cowen Adjusts Price Target on Charles River Laboratories International to $227 From $203, Maintains Hold Rating

Charles River (CRL) International Revenue in Focus: Trends and Expectations
CRL

Zacks

3 months ago

Charles River (CRL) International Revenue in Focus: Trends and Expectations

Charles River Laboratories to Present at UBS and Jefferies Conferences
CRL

Business Wire

3 months ago

Charles River Laboratories to Present at UBS and Jefferies Conferences

CRL

MT Newswires

3 months ago

Barrington Adjusts Price Target on Charles River Laboratories International to $212 From $194, Maintains Outperform Rating

Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
CRL

Simply Wall St.

3 months ago

Charles River Laboratories International Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

CRL

MT Newswires

3 months ago

Morgan Stanley Raises Charles River Laboratories International's Price Target to $225 From $215

CRL

MT Newswires

3 months ago

UBS Adjusts Price Target on Charles River Laboratories International to $250 From $240, Maintains Buy Rating

CRL

MT Newswires

3 months ago

Baird Adjusts Charles River Laboratories International Price Target to $211 From $190, Maintains Neutral Rating

CRL

MT Newswires

3 months ago

JPMorgan Adjusts Charles River Laboratories International Price Target to $215 From $195, Maintains Neutral Rating

CRL

MT Newswires

3 months ago

Evercore ISI Adjusts Charles River Laboratories International Price Target to $225 From $190, Maintains In Line Rating

CRL

Thomson Reuters StreetEvents

3 months ago

Q3 2024 Charles River Laboratories International Inc Earnings Call

CRL

Morningstar Research

3 months ago

Analyst Report: Charles River Laboratories International, Inc.

Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ...
CRL

GuruFocus.com

3 months ago

Charles River Laboratories International Inc (CRL) Q3 2024 Earnings Call Highlights: Navigating ...

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight
CRL

GuruFocus.com

3 months ago

Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall
CRL

Zacks

3 months ago

Charles River's Q3 Earnings, Revenues Beat Estimates, Margins Fall

CRL

MT Newswires

3 months ago

Deutsche Bank Raises Charles River Laboratories International Price Target to $250 From $235

Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
CRL

Zacks

3 months ago

Charles River (CRL) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates

CRL

MT Newswires

3 months ago

Sector Update: Health Care Stocks Advance Pre-Bell Wednesday

Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates
CRL

Zacks

3 months ago

Charles River Laboratories (CRL) Q3 Earnings and Revenues Beat Estimates

CRL

MT Newswires

3 months ago

Charles River Laboratories Q3 Non-GAAP Earnings, Revenue Decline; 2024 Outlook Lifted

CRL

Associated Press Finance

3 months ago

Charles River: Q3 Earnings Snapshot

Charles River Laboratories Announces Third-Quarter 2024 Results
CRL

Business Wire

3 months ago

Charles River Laboratories Announces Third-Quarter 2024 Results

Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics
CRL

Zacks

3 months ago

Gear Up for Charles River (CRL) Q3 Earnings: Wall Street Estimates for Key Metrics

Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates
CRL

Zacks

3 months ago

Pediatrix Medical Group (MD) Surpasses Q3 Earnings and Revenue Estimates

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?
CRL

Zacks

3 months ago

Charles River Laboratories (CRL) Expected to Beat Earnings Estimates: Should You Buy?

Why Charles River (CRL) is Poised to Beat Earnings Estimates Again
CRL

Zacks

3 months ago

Why Charles River (CRL) is Poised to Beat Earnings Estimates Again

CRL Gears Up for Q3 Earnings: Here's What You Need to Know
CRL

Zacks

3 months ago

CRL Gears Up for Q3 Earnings: Here's What You Need to Know

FibroBiologics and Charles River link for chronic disease therapies manufacture
CRL

Pharmaceutical Technology

3 months ago

FibroBiologics and Charles River link for chronic disease therapies manufacture

CRL

MT Newswires

4 months ago

FibroBiologics, Charles River Laboratories Team Up to Make Fibroblast-Based Treatments for Chronic Diseases

CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch
CRL

Zacks

4 months ago

CRL Stock Gains From New Retrogenix Non-Human Protein Library Launch

Charles River Launches New Retrogenix® Non-Human Protein Library
CRL

Business Wire

4 months ago

Charles River Launches New Retrogenix® Non-Human Protein Library

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
CRL

Business Wire

4 months ago

Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call

CRL

MT Newswires

4 months ago

Deutsche Bank Adjusts Charles River Laboratories International Price Target to $235 From $240, Maintains Buy Rating

CRL

MT Newswires

4 months ago

Barclays Adjusts Price Target on Charles River Laboratories International to $205 From $210

CRL

MT Newswires

4 months ago

JPMorgan Adjusts Charles River Laboratories International Price Target to $195 From $205, Maintains Neutral Rating

CRL

MT Newswires

4 months ago

--Redburn Atlantic Initiates Charles River Laboratories International at Sell With $151 Price Target

CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica
CRL

Zacks

4 months ago

CRL to Aid Lundbeck's Neurological Drug Research With AI-Backed Logica

CRL

MT Newswires

4 months ago

Goldman Sachs Adjusts Price Target on Charles River Laboratories International to $240 From $250, Maintains Buy Rating

CRL

MT Newswires

4 months ago

Evercore ISI Downgrades Charles River Laboratories International to In Line From Outperform, Adjusts PT to $190 From $225

Charles River Provides Translational Expertise at Neuroscience 2024
CRL

Business Wire

4 months ago

Charles River Provides Translational Expertise at Neuroscience 2024

CRL

MT Newswires

4 months ago

Charles River Laboratories International, Lundbeck Enter Deal for Logica Platform in Brain Disease Research

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease
CRL

Business Wire

4 months ago

Charles River and Lundbeck Enter Agreement Utilizing AI-Powered Logica® to Advance the Discovery of Novel Drugs for Neurological Disease

CRL

MT Newswires

4 months ago

BofA Securities Downgrades Charles River Laboratories International to Neutral From Buy on Biopharma Concerns, Price Target is $215

CRL

MT Newswires

4 months ago

Citigroup Downgrades Charles River Laboratories International to Sell From Neutral, Adjusts PT to $175 From $215

Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?
CRL

Simply Wall St.

4 months ago

Charles River Laboratories International, Inc.'s (NYSE:CRL) Recent Stock Performance Looks Decent- Can Strong Fundamentals Be the Reason?

CRL

MT Newswires

5 months ago

Baird Adjusts Charles River Laboratories International Price Target to $190 From $191

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
CRL

Zacks

5 months ago

CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA

CRL

MT Newswires

5 months ago

Charles River Laboratories, CEBINA Partner to Accelerate Neurodegenerative Drug Development

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research
CRL

Business Wire

5 months ago

Charles River Laboratories and CEBINA Announce Strategic Collaboration to Accelerate Cutting Edge Neuroscience Research

CRL Stock May Benefit From New Neuroscience Research Collaboration
CRL

Zacks

5 months ago

CRL Stock May Benefit From New Neuroscience Research Collaboration

Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
CRL

Zacks

5 months ago

Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
CRL

Insider Monkey

5 months ago

Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)

CRL

MT Newswires

5 months ago

Charles River Laboratories, Insightec Collaborate on Focused Ultrasound in Neuroscience

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
CRL

Business Wire

5 months ago

Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
CRL

Business Wire

5 months ago

Charles River Laboratories to Present at Baird and Morgan Stanley Conferences

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
CRL

Simply Wall St.

5 months ago

Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
CRL

Insider Monkey

5 months ago

Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment

Terumo and Charles River demonstrate effectiveness of CGT manufacturing device
CRL

Medical Device Network

6 months ago

Terumo and Charles River demonstrate effectiveness of CGT manufacturing device

CRL

Argus Research

6 months ago

Analyst Report: Charles River Laboratories Int

CRL

Argus Research

6 months ago

Market Digest: CRL, DE, EBAY, ES, PH, WWW

CRL

MT Newswires

6 months ago

Mizuho Adjusts Price Target on Charles River Laboratories International to $210 From $235, Maintains Neutral Rating

Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)
CRL

GuruFocus.com

6 months ago

Insider Sale: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL)

CRL

MT Newswires

6 months ago

Charles River Laboratories International Insider Sold Shares Worth $354,861, According to a Recent SEC Filing

Share on Social Networks: